Adele Barnard

Adele Barnard combines a PhD in Immunology with almost 20 years of experience in neuromodulation, having contributed to the development of some of the earliest waveforms and IPG systems in the mid-2000s. With extensive expertise in managing clinical trials in both the medical device and pharmacology sectors, she has led clinical research across Australia and held executive roles in prominent US companies, including Nevro and Abbott. Currently, Adele heads up a portfolio of clinical trials at Veritus Research in Australia. She also serves on human research ethics boards for medical device studies and consults to biotech companies, providing insights into the Australian regulatory landscape.